Yazar "Koksal, Deniz" seçeneğine göre listele

Listeleniyor 1 - 5 / 5
  • Küçük Resim Yok
    Öğe
    Management of bleeding risk before pleural procedures: A consensus statement of Turkish respiratory society - Pleura study group
    (Wolters Kluwer Medknow Publications, 2020) Demirci, Nilgun Yilmaz; Koksal, Deniz; Bilaceroglu, Semra; Ogan, Nalan; Atinkaya, Cansel; Ozhan, Mustafa; Ak, Guntulu
    Pleural effusion is a common clinical entity. Pleural procedures performed for the diagnosis and management of pleural effusions may increase the risk of bleeding, especially in patients with coagulopathies and comorbidities and those in need for antithrombotic drugs. Current literature provides sparse, low level of evidence, which is insufficient for safe implementation of pleural procedures among these patients. Thoracentesis, pleural biopsy (closed or percutaneous), catheter or chest tube drainage, and thoracoscopy are the main pleural procedures performed in these patients. Considering the bleeding risk associated with a specific pleural procedure, the risk is low for thoracentesis, moderate for insertion or removal of the chest tube or tunneled catheter, and moderate high for pleural biopsies and thoracoscopy. The current statement is prepared mainly for the pulmonologists and intended to provide recommendations to reduce the risk of bleeding following pleural procedures. The management of bleeding complication is out of the scope of this statement.
  • Küçük Resim Yok
    Öğe
    Patient and doctor delays in the diagnosis and treatment of non-small cell lung cancer in Turkey
    (European Respiratory Soc Journals Ltd, 2013) Yurdakul, Ahmet; Kocaturk, Celalettin; Bayiz, Hulya; Gursoy, Soner; Bircan, Ahmet; Ozcan, Aysenaz; Akkoclu, Atilla; Uluorman, Funda; Celik, Pinar; Koksal, Deniz; Ulubas, Bahar; Sercan, Eylem; Ozbudak, Omer; Goksel, Tuncay; Onalan, Tugba; Yamansavci, Esra; Turk, Figen; Yuncu, Gokhan; Copuraslan, Cigdem; Mardal, Tugba; Tuncay, Esin; Karamustafaoglu, Altemur; Yildiz, Pinar; Secik, Funda; Kaplan, Muhammet; Caglar, Emel; Ortakoylu, Mediha; Onal, Mine; Turna, Akif; Hekimoglu, Evlin; Dalar, Levent; Altin, Sedat; Gulhan, Meral; Akpinar, Eylem; Savas, Ismail; Firat, Nalan; Camsari, Gungor; Ozkan, Gulcihan; Cetinkaya, Erdogan; Kamiloglu, Emine; Celik, Bulent; Havlucu, Yavuz
  • Küçük Resim Yok
    Öğe
    Patient and physician delay in the diagnosis and treatment of non-small cell lung cancer in Turkey
    (Elsevier Sci Ltd, 2015) Yurdakul, Ahmet Selim; Kocaturk, Celalettin; Bayiz, Hulya; Gursoy, Soner; Bircan, Ahmet; Ozcan, Aysenaz; Akkoclu, Atilla; Uluorman, Funda; Celik, Pinar; Koksal, Deniz; Ulubas, Bahar; Sercan, Eylem; Ozbudak, Omer; Goksel, Tuncay; Onalan, Tugba; Yamansavci, Esra; Turk, Figen; Yuncu, Gokhan; Copuraslan, Cigdem; Mardal, Tugba; Tuncay, Esin; Karamustafaoglu, Altemur; Yildiz, Pinar; Secik, Funda; Kaplan, Muhammet; Caglar, Emel; Ortakoylu, Mediha; Onal, Mine; Turna, Akif; Hekimoglu, Evlin; Dalar, Levent; Altin, Sedat; Gulhan, Meral; Akpinar, Eylem; Savas, Ismail; Firat, Nalan; Camsari, Gungor; Ozkan, Gulcihan; Cetinkaya, Erdogan; Kamiloglu, Emine; Celik, Bulent; Havlucu, Yavuz
    Aim: The early diagnosis and treatment of lung cancer are important for the prognosis of patients with lung cancer. This study was undertaken to investigate patient and doctor delays in the diagnosis and treatment of NSCLC and the factors affecting these delays. Materials and methods: A total of 1016 patients, including 926 (91.1%) males and 90 (8.9%) females with a mean age of 61.5 +/- 10.1 years, were enrolled prospectively in this study between May 2010 and May 2011 from 17 sites in various Turkish provinces. Results: The patient delay was found to be 49.9 +/- 96.9 days, doctor delay was found to be 87.7 +/- 99.6 days, and total delay was found to be 131.3 +/- 135.2 days. The referral delay was found to be 61.6 +/- 127.2 days, diagnostic delay was found to be 20.4 +/- 44.5 days, and treatment delay was found to be 24.4 +/- 54.9 days. When the major factors responsible for these delays were examined, patient delay was found to be more frequent in workers, while referral delay was found to be more frequent in patients living in villages (p < 0.05). We determined that referral delay, doctor delay, and total delay increased as the number of doctors who were consulted by patients increased (p < 0.05). Additionally, we determined that diagnostic and treatment delays were more frequent at the early tumour stages in NSCLC patients (p < 0.05). Discussion: The extended length of patient delay underscores the necessity of educating people about lung cancer. To decrease doctor delay, education is a crucial first step. Additionally, to further reduce the diagnostic and treatment delays of chest specialists, multidisciplinary management and algorithms must be used regularly. (C) 2015 Elsevier Ltd. All rights reserved.
  • Küçük Resim Yok
    Öğe
    Patient and physician delay in the diagnosis and treatment of non-small cell lung cancer in Turkey
    (Elsevier Sci Ltd, 2015) Yurdakul, Ahmet Selim; Kocaturk, Celalettin; Bayiz, Hulya; Gursoy, Soner; Bircan, Ahmet; Ozcan, Aysenaz; Akkoclu, Atilla; Uluorman, Funda; Celik, Pinar; Koksal, Deniz; Ulubas, Bahar; Sercan, Eylem; Ozbudak, Omer; Goksel, Tuncay; Onalan, Tugba; Yamansavci, Esra; Turk, Figen; Yuncu, Gokhan; Copuraslan, Cigdem; Mardal, Tugba; Tuncay, Esin; Karamustafaoglu, Altemur; Yildiz, Pinar; Secik, Funda; Kaplan, Muhammet; Caglar, Emel; Ortakoylu, Mediha; Onal, Mine; Turna, Akif; Hekimoglu, Evlin; Dalar, Levent; Altin, Sedat; Gulhan, Meral; Akpinar, Eylem; Savas, Ismail; Firat, Nalan; Camsari, Gungor; Ozkan, Gulcihan; Cetinkaya, Erdogan; Kamiloglu, Emine; Celik, Bulent; Havlucu, Yavuz
    Aim: The early diagnosis and treatment of lung cancer are important for the prognosis of patients with lung cancer. This study was undertaken to investigate patient and doctor delays in the diagnosis and treatment of NSCLC and the factors affecting these delays. Materials and methods: A total of 1016 patients, including 926 (91.1%) males and 90 (8.9%) females with a mean age of 61.5 +/- 10.1 years, were enrolled prospectively in this study between May 2010 and May 2011 from 17 sites in various Turkish provinces. Results: The patient delay was found to be 49.9 +/- 96.9 days, doctor delay was found to be 87.7 +/- 99.6 days, and total delay was found to be 131.3 +/- 135.2 days. The referral delay was found to be 61.6 +/- 127.2 days, diagnostic delay was found to be 20.4 +/- 44.5 days, and treatment delay was found to be 24.4 +/- 54.9 days. When the major factors responsible for these delays were examined, patient delay was found to be more frequent in workers, while referral delay was found to be more frequent in patients living in villages (p < 0.05). We determined that referral delay, doctor delay, and total delay increased as the number of doctors who were consulted by patients increased (p < 0.05). Additionally, we determined that diagnostic and treatment delays were more frequent at the early tumour stages in NSCLC patients (p < 0.05). Discussion: The extended length of patient delay underscores the necessity of educating people about lung cancer. To decrease doctor delay, education is a crucial first step. Additionally, to further reduce the diagnostic and treatment delays of chest specialists, multidisciplinary management and algorithms must be used regularly. (C) 2015 Elsevier Ltd. All rights reserved.
  • Küçük Resim Yok
    Öğe
    Patient and physician delay in the diagnosis and treatment of non-small cell lung cancer in Turkey
    (Elsevier Sci Ltd, 2015) Yurdakul, Ahmet Selim; Kocaturk, Celalettin; Bayiz, Hulya; Gursoy, Soner; Bircan, Ahmet; Ozcan, Aysenaz; Akkoclu, Atilla; Uluorman, Funda; Celik, Pinar; Koksal, Deniz; Ulubas, Bahar; Sercan, Eylem; Ozbudak, Omer; Goksel, Tuncay; Onalan, Tugba; Yamansavci, Esra; Turk, Figen; Yuncu, Gokhan; Copuraslan, Cigdem; Mardal, Tugba; Tuncay, Esin; Karamustafaoglu, Altemur; Yildiz, Pinar; Secik, Funda; Kaplan, Muhammet; Caglar, Emel; Ortakoylu, Mediha; Onal, Mine; Turna, Akif; Hekimoglu, Evlin; Dalar, Levent; Altin, Sedat; Gulhan, Meral; Akpinar, Eylem; Savas, Ismail; Firat, Nalan; Camsari, Gungor; Ozkan, Gulcihan; Cetinkaya, Erdogan; Kamiloglu, Emine; Celik, Bulent; Havlucu, Yavuz
    Aim: The early diagnosis and treatment of lung cancer are important for the prognosis of patients with lung cancer. This study was undertaken to investigate patient and doctor delays in the diagnosis and treatment of NSCLC and the factors affecting these delays. Materials and methods: A total of 1016 patients, including 926 (91.1%) males and 90 (8.9%) females with a mean age of 61.5 +/- 10.1 years, were enrolled prospectively in this study between May 2010 and May 2011 from 17 sites in various Turkish provinces. Results: The patient delay was found to be 49.9 +/- 96.9 days, doctor delay was found to be 87.7 +/- 99.6 days, and total delay was found to be 131.3 +/- 135.2 days. The referral delay was found to be 61.6 +/- 127.2 days, diagnostic delay was found to be 20.4 +/- 44.5 days, and treatment delay was found to be 24.4 +/- 54.9 days. When the major factors responsible for these delays were examined, patient delay was found to be more frequent in workers, while referral delay was found to be more frequent in patients living in villages (p < 0.05). We determined that referral delay, doctor delay, and total delay increased as the number of doctors who were consulted by patients increased (p < 0.05). Additionally, we determined that diagnostic and treatment delays were more frequent at the early tumour stages in NSCLC patients (p < 0.05). Discussion: The extended length of patient delay underscores the necessity of educating people about lung cancer. To decrease doctor delay, education is a crucial first step. Additionally, to further reduce the diagnostic and treatment delays of chest specialists, multidisciplinary management and algorithms must be used regularly. (C) 2015 Elsevier Ltd. All rights reserved.